Bioprinted Organs
Posted in biotech/medical
Category: biotech/medical – Page 1278
To watch the full interview, visit: http://www.yiddishbookcenter.org/oral…
Leonard Nimoy — Jewish actor best known for his role as Spock on the Star Trek science fiction series — explains the Jewish story behind the hand-gesture he made famous through his role as Spock in the Star Trek science fiction series.
Researchers at the University of Texas have discovered a new way for neural networks to simulate symbolic reasoning. This discovery sparks an exciting path toward uniting deep learning and symbolic reasoning AI.
In the new approach, each neuron has a specialized function that relates to specific concepts. “It opens the black box of standard deep learning models while also being able to handle more complex problems than what symbolic AI has typically handled,” Paul Blazek, University of Texas Southwestern Medical Center researcher and one of the authors of the Nature paper, told VentureBeat.
This work complements previous research on neurosymbolic methods such as MIT’s Clevrer, which has shown some promise in predicting and explaining counterfactual possibilities more effectively than neural networks. Additionally, DeepMind researchers previously elaborated on another neural network approach that outperformed state-of-the-art neurosymbolic approaches.
Stein Emil Vollset, the study’s lead author and Professor of Global Health at the Institute for Health Metrics and Evaluation (IHME), elaborated on the findings.
“The last time that global population declined was in the mid 14th century, due to the Black Plague,” he told IFLScience. “If our forecast is correct, it will be the first time population decline is driven by fertility decline, as opposed to events such as a pandemic or famine.”
Some countries, however, are forecasted to see an increase in population.
which envisions coordinating hundreds of #robots for missions in urban areas. http://ow.ly/OtWm50H8by5
Researchers have refined a molecule that shows promise for the prevention of Parkinson’s disease.
Researchers have refined a molecule that shows promise for the prevention of Parkinson’s disease.… See more.
Summary: Researchers have refined a molecule that shows promise for the prevention of Parkinson’s disease.
Source: University of Bath
A molecule that shows promise in preventing Parkinson’s disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
Experimental compound, which has received orphan drug and pediatric rare disease designations from the FDA, displays effectiveness in treating symptoms of Autism and Alzheimer’s disease. Researchers developed a novel model to assess the effect of this experimental drug on symptoms related to au.
After DeepMind’s breakthrough in protein folding last year, Alphabet will double down on artificial intelligence in biology and health with its new venture.
A newly approved eye drop hitting the market on Thursday could change the lives of millions of Americans with age-related blurred near vision, a condition affecting mostly people 40 and older.
Vuity, which was approved by the Food and Drug Administration in October, would potentially replace reading glasses for some of the 128 million Americans who have trouble seeing close-up. The new medicine takes effect in about 15 minutes, with one drop on each eye providing sharper vision for six to 10 hours, according to the company.
Toni Wright, one of the 750 participants in a clinical trial to test the drug, said she liked what she saw.
The brain is considered a very expensive organ to run.
Your brain may be leaking … energy, according to a new study that may explain why your noggin consumes 20% of the energy needed to keep your body running.
The study researchers found that tiny sacs called vesicles that hold messages being transmitted between brain cells may be constantly oozing energy, and that leakage is likely a trade-off for the brain being ready to fire at all times, according to a new study published Dec. 3 in the journal Science Advances.